ReNerve Statistics

Total Valuation

ReNerve has a market cap or net worth of AUD 15.68 million. The enterprise value is 9.29 million.

Market Cap	15.68M
Enterprise Value	9.29M

Important Dates

The last earnings date was Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

ReNerve has 142.50 million shares outstanding.

Current Share Class	142.50M
Shares Outstanding	142.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	35.05%
Owned by Institutions (%)	2.70%
Float	64.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	64.97
PB Ratio	2.25
P/TBV Ratio	2.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.72
EV / Sales	38.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.47

Financial Position

The company has a current ratio of 17.55

Current Ratio	17.55
Quick Ratio	16.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.67

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-49.49%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	0.11
200-Day Moving Average	n/a
Relative Strength Index (RSI)	47.99
Average Volume (20 Days)	20,672

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ReNerve had revenue of AUD 241,270 and -3.41 million in losses. Loss per share was -0.02.

Revenue	241,270
Gross Profit	238,806
Operating Income	-3.47M
Pretax Income	-3.41M
Net Income	-3.41M
EBITDA	-3.36M
EBIT	-3.47M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 6.39 million in cash and n/a in debt, giving a net cash position of 6.39 million or 0.04 per share.

Cash & Cash Equivalents	6.39M
Total Debt	n/a
Net Cash	6.39M
Net Cash Per Share	0.04
Equity (Book Value)	6.97M
Book Value Per Share	0.05
Working Capital	6.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.65 million and capital expenditures -25,184, giving a free cash flow of -2.68 million.

Operating Cash Flow	-2.65M
Capital Expenditures	-25,184
Free Cash Flow	-2.68M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross Margin	98.98%
Operating Margin	-1,436.93%
Pretax Margin	-1,412.78%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ReNerve does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-21.74%
FCF Yield	-17.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ReNerve has an Altman Z-Score of 28.92.

Altman Z-Score	28.92
Piotroski F-Score	n/a